a public good project by the
Synthesis
Company
of California

© 2026

Patricia Fast | doi.page

0 works0 citations0 h-index

Patricia Fast

International AIDS Vaccine Initiative(US)Stanford University(US)

Publications by Year

Research Areas

HIV Research and Treatment, HIV/AIDS Research and Interventions, Vaccine Coverage and Hesitancy, HIV/AIDS drug development and treatment, Viral Infections and Outbreaks Research

Most-Cited Works

→ Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm(2009)578 cited
→ Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe(2015)409 cited
→ Vaccine Development to Prevent Cytomegalovirus Disease: Report from the National Vaccine Advisory Committee(2004)330 cited
→ The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial(2015)277 cited
→ A human protein specific for the immunoglobulin octamer DNA motif contains a functional homeobox domain(1988)232 cited
→ Immune activation alters cellular and humoral responses to yellow fever 17D vaccine(2014)221 cited

→ Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV‐1_Mngp120, HIV‐1_SF2Recombinant gp120, or Both Vaccines in Seronegative Adults(1998)190 cited

→ In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers(2011)185 cited

→ A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+Cytotoxic T Lymphocyte Responses in Seronegative Volunteers(1999)173 cited

→ Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers(2012)151 cited